Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia

Schizophrenia Research

Volumn 49, Issue 1-2, 2001, Pages 89-98

  Webster, Maree J ^a   Shannon Weickert, Cynthia ^b   Herman, Mary M ^b   Hyde, Thomas M ^b   Kleinman, Joel E ^b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

GAP 43 mRNA; Growth associated protein 43; In situ hybridization; Neuroleptic treatment; Schizophrenia; Synaptophysin

Indexed keywords

BRAIN PROTEIN; MESSENGER RNA; NEUROMODULIN; SYNAPTOPHYSIN;

ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; SCHIZOPHRENIA; TISSUE LEVEL;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; CULTURE TECHNIQUES; FEMALE; GAP-43 PROTEIN; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PRESYNAPTIC TERMINALS; RNA, MESSENGER; SCHIZOPHRENIA; SYNAPTOPHYSIN; TEMPORAL LOBE;

EID: 0343832093     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(00)00052-9     Document Type: Article

References (61)

1. Aigner L., Caroni P. Depletion of 43 kDa growth-associated protein in primary sensory neurons leads to diminished formation and spreading of growth cones. J. Cell Biol. 123:1993;417-429.
2. Akbarian S., Vinuela A., Kim J.J., Potkin S.G., Bunney B.E., Jones E.G. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch. Gen. Psychiatry. 50:1993;178-187.
3. Alder J., Kanki H., Valtorta F., Greengard P., Poo M. Overexpression of synaptophysin enhances neurotransmitter secretion at Xenopus neuromuscular synapses. J. Neurosci. 15:1995;511-519.
4. Alder J., Lu B., Valtorta F., Greengard P., Poo M. Calcium-dependent transmitter secretion reconstituted in Xenopus oocytes: requirement for synaptophysin. Science. 257:1992;657-661.
5. Arnold S.E., Franz B.R., Gur R.C., Gur R.E., Shapiro R.M., Moberg P.J., Trojanowski J.Q. Small neuron size in schizophrenia in hippocampal subfields that mediate cortico-hippocampal interactions. Am. J. Psychiatry. 152:1995;738-748.
6. Arnold S.E., Hyman B.T., Van Hoesen G.W., Damasio A.R. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch. Gen. Psychiatry. 48:1991;625-632.
7. Benowitz L., Routtenberg A. GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci. 20:1997;84-91.
8. Benowitz L., Apostolides P.J., Peronne-Bizzozero N., Finklestein S.P., Zwiers H. Anatomical distribution of the growth-associated protein GAP-43/B-50 in the adult rat brain. J. Neurosci. 8:1988;339-352.
9. Benowitz L., Peronne-Bizzozero N., Finklestein S.P., Bird E.B. Localization of the growth associated phosphoprotein GAP-43 (B-50,F1) in the human cerebral cortex. J. Neurosci. 9:1989;990-995.
10. Bogerts B., Falkai P., Haupts M. Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Schizophr. Res. 3:1990;295-301.
11. Brown R., Colter N., Corsellis J.A.N., Crow T.J., Frith C.D., Jagoe R., Johnstone E.C., Marsh L. Postmortem evidence of structural brain changes in schizophrenia. Difference in brain weight, temporal horn area and parahippocampal gyrus compared with affective disorder. Arch. Gen. Psychiatry. 43:1986;36-42.
12. Browning M.D., Dudek E.M., Rapier J.L., Leonard S., Freedman R. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol. Psychiatry. 34:1993;529-535.
13. Callahan L., Selski D.J., Martzen M.R., Cheetham J.E., Coleman P.D. Preliminary evidence: decreased GAP-43 message in tangle bearing neurons relative to adjacent tangle-free neurons in Alzheimer's disease parahippocampal gyrus. Neurobiol. Aging. 15:1994;381-386.
14. Collinge, J., Curtis, D., 1991. Decreased hippocampol expression of a glutonate receptor gene in schizophenia. Br. J. Psychiatry 159, 857-859.
15. Conrad A.J., Abebe T., Austin R., Forsythe S., Scheibel A. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch. Gen. Psychiatry. 48:1991;413-417.
16. Dekker L.V., De Graan P.N.E., Oestriecher A.B., Verstaag D.H.G., Gispen W.H. Inhibition of noradrenaline release by antibodies to B-50 (GAP-43). Nature. 34:1989;274-276.
17. Eastwood S.L., Burnet P.W.J., Harrison P.J. Striatal synaptophysin and haloperidol-induced synaptic plasticity. Neuroreport. 5:1994;677-680.
18. Eastwood S.L., Burnet P.W.J., Harrison P.J. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience. 66:1995;309-319.
19. Eastwood S.L., Burnet P.W.J., McDonald B., Clinton J., Harrison P.J. Synaptophysin gene expression in human brain: a quantitative in situ hybridization and immunocytochemical study. Neuroscience. 59:1994;881-892.
20. Eastwood, S.L., Harrison, P.J., 1995. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoeautoradiography. Neuroscience 69, 339-343.
21. Eastwood S.L., Harrison P.J. Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia. Neuroscience. 86:1998;437-448.
22. Eastwood S.L., Harrison P.J. Detection and quantitation of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed paraffin embedded sections. Neuroscience. 93:1999;99-109.
23. Eastwood S.L., Heffernan J., Harrison P.J. Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes. Mol. Psychiatry. 2:1997;322-329.
24. Eastwood S.L., McDonald B., Burnet P.W.J., Beckwith J.P., Kerwin R.W., Harrison P.J. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Mol. Brain Res. 29:1995;211-223.
25. Glanz L.A., Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia:regional and diagnostic specificity. Arch. Gen. Psychiatry. 54:1997;660-669.
26. Hamos J.E., Degennaro L.J., Drachman D.A. Synaptic loss in Alzheimer's disease and other dementias. Neurology. 39:1989;355-361.
27. Harrison P.J., Eastwood S.L. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet. 352:1998;1669-1673.
28. Harrison P.J., Heath P.R., Eastwood S.L., Burnet P.W.J., McDonald B., Pearson R.C.A. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci. Lett. 200:1995;151-154.
29. Harrison P.J., McLaughlin D., Kerwin R. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet. 337:1991;450-452.
30. Heckers S., Heinsen H., Geiger B., Beckman H. Hippocampal neuron number in schizophrenia. A stereological study. Arch. Gen. Psychiatry. 48:1991;1002-1008.
31. Insausti R., Tunon T., Sobreviela T., Insausti A.M., Gonzalo L.M. The human entorhinal cortex: a cytoarchitectonic analysis. J. Comp. Neurol. 355:1995;171-198.
32. Ivins K.J., Neve K.A., Feller D.J., Fidel S.A., Neve R.L. Antisense GAP-43 inhibits the evoked release of dopamine from PC12 cells. J. Neurochem. 60:1993;626-633.
33. Jacob H., Beckman H. Circumscribed malformation and nerve cell alterations in the entorhinal cortex in schizophrenics. J. Neural Transm. 98:1994;83-106.
34. Jahn R., Scheibler W., Ouimet C., Greengard P. A 38,000-dalton membrane protein (p38) present in synaptic vesicles. Proc. Natl. Acad. Sci. USA. 82:1985;4137-4141.
35. Jeste D.V., Lohr J.B. Hippocampal pathologic findings in schizophrenia. A morphometric study. Arch. Gen. Psychiatry. 46:(11):1989;1019-1024.
36. Kleinman J.E., Hyde T.M., Herman M.M. Methodological issues in the neuropathology of mental illness. Bloom F.E., Kupfer D.J. Psycopharmacology: The Fourth Generation of Progress. 1995;859-864 Raven Press, New York.
37. Kosik K.S., Orecchio L.D., Bruns G.A.P., Benowitz L.I., MacDonald G.P., Cox D.R., Neve R.L. Human GAP-43: Its deduced amino acid sequence and chromosomal localization in mouse and human. Neuron. 1:1988;127-132.
38. Krimer L.S., Herman M.M., Saunders R.C., Boyd J.C., Hyde T.M., Carter J.M., Kleinman J.E., Weinberger D.R. A quantitative and qualitative analysis of entorhinal cortex in schizophrenia. Cerebral Cortex. 7:1997;732-739.
39. Krimer L.S., Hyde T.M., Herman M.M., Saunders R.C. The entorhinal cortex: an examination of cyto- and myeloarchitectonic organization in humans. Cerebral Cortex. 7:1997;722-731.
40. Masliah E., Terry R.D., Alford M., DeTeresa R. Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J. Histochem. Cytochem. 38:1990;837-844.
41. Masliah E., Fagan A.M., Terry R.D., DeTeresa R., Mallory M., Gage F.H. Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat. Exp. Neurol. 113:1991;131-142.
42. Masliah E., Terry R.D., Alford M., DeTeresa R., Hansen L.A. Cortical and subcortical patterns of synaptophysin like immunoreactivity in Alzheimer's disease. Am. J. Pathol. 138:1991;235-246.
43. Meberg P.J., Valcourt E.G., Routtenberg A. Protein F1/GAP-43 and PKC gene expression patterns in hippocampus are altered 1-2 hr after LTP. Mol. Brain Res. 34:1995;343-346.
44. Melloni R.H., Hemmendinger L.M., Hamos J.E., DeGennaro L.J. Synapsin I gene expression in the adult rat brain with comparative analysis of mRNA and protein in the hippocampus. J. Comp. Neurol. 327:1993;507-520.
45. Navone F., Jahn R., Di Gioia G., Stukenbrok H., Greengard P., De Camilli P. Protein p38: an intergral membrane protein specific for small vesicles and neuroendocrine cells. J. Cell Biol. 103:1986;2511-2527.
46. Neve R.L., Finch E.A., Bird E.D., Benowitz L.I. Growth-associated protein GAP-43 is expressed selectively in associative regions of the adult human brain. Proc. Natl. Acad. Sci. USA. 85:1988;3638-3642.
47. Perrone-Bizzozero N.I., Sower A.C., Bird E.D., Benowitz L.I., Ivans K.J., Neve R.L. Levels of growth associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc. Natl. Acad. Sci. USA. 93:1996;14182-14187.
48. Reynolds, G.P., Czudek, G., Andrews, H.B., 1990. Deficit and hemispheric assymetry of GABA uptake sites in the hippocampus in schizophrenia. Biol. Psych. 27, 1038-1044.
49. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex - a morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry. 52:1995;805-818.
50. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: Application of a three dimensional, stereologic counting method. J. Comp. Neurol. 392:1998;402-412.
51. Shannon-Weickert C., Webster M.J., Hyde T.H., Herman M.M., Weinberger D.R., Kleinman J.E. Reduced expression of GAP-43 mRNA in prefrontal cortex of patients with schizophrenia. Cerebral Cortex. 1999;. submitted.
52. Snedecor G.W., Cochran W.G. Statistical Methods. sixth ed. 1976;The Iowa State University Press, Ames, IA.
53. Sower A.C., Bird E.D., Perrone-Bizzozero N.I. Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method. Mol. Chem. Neuropathol. 24:1995;1-11.
54. Strittmatter S.M., Fankhauser C., Haung P.L., Mashimo H., Fishman M.C. Neuronal pathfinding is abnormal in mice lacking the neuronal growth cone protein GAP-43. Cell. 80:1995;445-452.
55. Suddath R.L., Casanova M.D., Goldberg T.E., Daniel D.G., Kelsoe J.R., Weinberger D.R. Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. Am. J. Psychiatry. 146:1989;464-472.
56. Vawter M.P., Howard A.L., Hyde T.M., Kleinman J.E., Freed W.J. Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia. Mol. Psychiatry. 4:1999;467-475.
57. Walaas I., Jahn R., Greengard P. Quantitation of nerve terminal populations: synaptic vesicle-associated proteins as markers for synaptic density in the rat neostriatum. Synapse. 2:1988;516-520.
58. Webster M.J., Shannon-Weickert C., Herman M.M., Hyde T.M., Kleinman J.E. Localization of GAP-43 and BDNF mRNA in the human visual cortex during postnatal development. Neurosci. Abstr. 23:1997;81.
59. Whitfield H.J., Brady L.S., Smith M.A., Mamalaki E., Fox R.J., Herkenham M. Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol. Cell. Mol. Neurobiol. 10:1990;145-157.
60. r 38,000 characteristic of presynaptic vesicles. Cell. 41:1985;1017-1028.
61. Young C.E., Arima K., Xie J., Hu L., Beach T.G., Falkai P., Honer W.G. SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cerebral Cortex. 8:1998;1047-3211.